YokoCo

The Food and Drug Administration has approved crizotinib (Xalkori) to treat adult and pediatric patients ages one year and older who have recurrent or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors.The most common adverse effects in adults are vision disorders, nausea, and edema. The most common adverse effects in pediatric patients are vomiting, nausea, diarrhea, abdominal pain, rash, vision disorder, upper respiratory tract infection, cough, pyrexia, musculoskeletal pain, fatigue, edema, constipation, and headache.

Acute mesenteric ischemia (AMI) is a group of diseases characterized by an interruption of the blood supply to varying portions of the intestine, leading to ischemia and secondary inflammatory changes. If untreated, this process may progress to life-threatening intestinal necrosis. The incidence is low, estimated at 0.09-0.2% of all acute surgical admissions, but increases with age. Although the entity is an uncommon cause of abdominal pain, diligence is required because if untreated, mortality remains in the range of 50%. Early diagnosis and timely surgical intervention are the cornerstones of modern treatment to reduce the high mortality associated with this entity. The advent of endovascular approaches in parallel with modern imaging techniques is evolving and provides new treatment options. Lastly, a focused multidisciplinary approach based on early diagnosis and individualized treatment is essential. Thus, we believe that updated guidelines from World Society of Emergency Surgery are warranted, in order to provide the most recent and practical recommendations for diagnosis and treatment of AMI.

Investigate the survival and risk factors that affect the survival of aged patients in a palliative care center (PCC).

Patients with haemophilic arthropathy suffer chronic pain that affects and restricts their quality of life. Visualization of movement through immersive virtual reality is used for pain management.

While migraine is the most common headache disorder in children and adolescents presenting to a neurologist, other primary headache disorders are important to recognize. Trigeminal autonomic cephalalgias represent a rare group of primary headache disorders with different characteristics, workup and management. Here, we present an adolescent with one common and one unique headache phenotype followed by a guided discussion of the differential diagnoses, workup, treatments and a brief summary of further management considerations.

Hand dermatitis (HD) is an inflammatory disorder of the hand. Agricultural industries (farming) have been reported as one of the leading occupation predisposing workers to health risks. Practices such as dumping cassava peels in farm environment, removal of heaps of peels, soaking of cassava and clearing of ditches have been identified as potentially harmful. These processes, which are wet works, are often done with bare hands predisposing cassava processors to HD.

Pain is a distressful feeling that is frequently caused by intense or damaging chemical, thermal or mechanical stimuli. It can also occur without tissue damage or injury, although the patient makes reference to it. Pain is one of the body's most important communication tools, and a protective mechanism by which the body responds to noxious or harmful stimuli. The cascade of molecular events that culminate in the experience of pain in an individual is a complex neural phenomenon in which inordinate (excess) noxious peripheral stimuli are processed.

Vitiligo is a chronic autoimmune disease that causes skin depigmentation. A cream formulation of ruxolitinib (an inhibitor of Janus kinase 1 and 2) resulted in repigmentation in a phase 2 trial involving adults with vitiligo.

The aim of this study was to evaluate the intracanal effectiveness of cryotherapy, curcumin irrigant, and normal saline as a final irrigant in reducing postendodontic pain in primary teeth.

Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, characterized by the development of auto-antibodies against hemidesmosomal components BP180 and BP230. The mainstay of therapy are topical and systemic corticosteroids (CS) and immunosuppressors. As this pathology mainly involves the elderly, subjects often have numerous comorbidities that influence the clinical management. Omalizumab is a recombinant humanized monoclonal anti-IgE antibody which has recently emerged as a promising treatment for BP in patients for whom CS are contraindicated or conventional treatments have failed to control the disease.